nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0314	0.0714	CbGeAlD
Amoxapine—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0233	0.0604	CcSEcCtD
Amoxapine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0203	0.0461	CbGeAlD
Amoxapine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.017	0.0386	CbGeAlD
Amoxapine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0412	CcSEcCtD
Amoxapine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.015	0.0388	CcSEcCtD
Amoxapine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0355	CcSEcCtD
Amoxapine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0131	0.0298	CbGeAlD
Amoxapine—HTR7—pons—amyotrophic lateral sclerosis	0.013	0.0295	CbGeAlD
Amoxapine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0297	CcSEcCtD
Amoxapine—Mazindol—SIGMAR1—amyotrophic lateral sclerosis	0.011	1	CrCbGaD
Amoxapine—DRD1—nerve—amyotrophic lateral sclerosis	0.0108	0.0244	CbGeAlD
Amoxapine—HTR3A—nerve—amyotrophic lateral sclerosis	0.0104	0.0236	CbGeAlD
Amoxapine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00977	0.0253	CcSEcCtD
Amoxapine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00914	0.0237	CcSEcCtD
Amoxapine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00881	0.0229	CcSEcCtD
Amoxapine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0087	0.0226	CcSEcCtD
Amoxapine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00865	0.0196	CbGeAlD
Amoxapine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00863	0.0196	CbGeAlD
Amoxapine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0224	CcSEcCtD
Amoxapine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00848	0.022	CcSEcCtD
Amoxapine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00819	0.0186	CbGeAlD
Amoxapine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00811	0.021	CcSEcCtD
Amoxapine—HTR2A—pons—amyotrophic lateral sclerosis	0.00809	0.0184	CbGeAlD
Amoxapine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00777	0.0201	CcSEcCtD
Amoxapine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00768	0.0199	CcSEcCtD
Amoxapine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00698	0.0158	CbGeAlD
Amoxapine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00692	0.018	CcSEcCtD
Amoxapine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0069	0.0157	CbGeAlD
Amoxapine—HTR7—nerve—amyotrophic lateral sclerosis	0.00673	0.0153	CbGeAlD
Amoxapine—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00654	0.0148	CbGeAlD
Amoxapine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00652	0.0169	CcSEcCtD
Amoxapine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00651	0.0169	CcSEcCtD
Amoxapine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00648	0.0147	CbGeAlD
Amoxapine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00643	0.0167	CcSEcCtD
Amoxapine—DRD2—nerve—amyotrophic lateral sclerosis	0.00636	0.0144	CbGeAlD
Amoxapine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00633	0.0144	CbGeAlD
Amoxapine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00621	0.0161	CcSEcCtD
Amoxapine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00617	0.016	CcSEcCtD
Amoxapine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00614	0.0159	CcSEcCtD
Amoxapine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00614	0.0159	CcSEcCtD
Amoxapine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00594	0.0135	CbGeAlD
Amoxapine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00592	0.0134	CbGeAlD
Amoxapine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00588	0.0152	CcSEcCtD
Amoxapine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0147	CcSEcCtD
Amoxapine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0146	CcSEcCtD
Amoxapine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0146	CcSEcCtD
Amoxapine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00538	0.0122	CbGeAlD
Amoxapine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00527	0.012	CbGeAlD
Amoxapine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00504	0.0114	CbGeAlD
Amoxapine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.005	0.013	CcSEcCtD
Amoxapine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00486	0.011	CbGeAlD
Amoxapine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00485	0.0126	CcSEcCtD
Amoxapine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00483	0.0125	CcSEcCtD
Amoxapine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00482	0.0125	CcSEcCtD
Amoxapine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00478	0.0124	CcSEcCtD
Amoxapine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00477	0.0108	CbGeAlD
Amoxapine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00462	0.0105	CbGeAlD
Amoxapine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00461	0.012	CcSEcCtD
Amoxapine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0117	CcSEcCtD
Amoxapine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00447	0.0101	CbGeAlD
Amoxapine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0114	CcSEcCtD
Amoxapine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00441	0.0114	CcSEcCtD
Amoxapine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00435	0.0113	CcSEcCtD
Amoxapine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0112	CcSEcCtD
Amoxapine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0111	CcSEcCtD
Amoxapine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00425	0.011	CcSEcCtD
Amoxapine—HTR2A—nerve—amyotrophic lateral sclerosis	0.0042	0.00953	CbGeAlD
Amoxapine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0106	CcSEcCtD
Amoxapine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0105	CcSEcCtD
Amoxapine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0104	CcSEcCtD
Amoxapine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00395	0.0102	CcSEcCtD
Amoxapine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0102	CcSEcCtD
Amoxapine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0102	CcSEcCtD
Amoxapine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00993	CcSEcCtD
Amoxapine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00973	CcSEcCtD
Amoxapine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00375	0.0085	CbGeAlD
Amoxapine—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00375	0.0085	CbGeAlD
Amoxapine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00372	0.00843	CbGeAlD
Amoxapine—DRD4—brain—amyotrophic lateral sclerosis	0.00368	0.00835	CbGeAlD
Amoxapine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00942	CcSEcCtD
Amoxapine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00935	CcSEcCtD
Amoxapine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00359	0.00815	CbGeAlD
Amoxapine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00926	CcSEcCtD
Amoxapine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00917	CcSEcCtD
Amoxapine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00905	CcSEcCtD
Amoxapine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00898	CcSEcCtD
Amoxapine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00891	CcSEcCtD
Amoxapine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.0034	0.00773	CbGeAlD
Amoxapine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00338	0.00768	CbGeAlD
Amoxapine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00858	CcSEcCtD
Amoxapine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00852	CcSEcCtD
Amoxapine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00326	0.00739	CbGeAlD
Amoxapine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00326	0.00739	CbGeAlD
Amoxapine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00827	CcSEcCtD
Amoxapine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00823	CcSEcCtD
Amoxapine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00823	CcSEcCtD
Amoxapine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00314	0.00713	CbGeAlD
Amoxapine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00313	0.00712	CbGeAlD
Amoxapine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00302	0.00686	CbGeAlD
Amoxapine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.003	0.0068	CbGeAlD
Amoxapine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00289	0.00656	CbGeAlD
Amoxapine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00747	CcSEcCtD
Amoxapine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00286	0.0065	CbGeAlD
Amoxapine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00737	CcSEcCtD
Amoxapine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00279	0.00632	CbGeAlD
Amoxapine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00713	CcSEcCtD
Amoxapine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00273	0.0062	CbGeAlD
Amoxapine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00689	CcSEcCtD
Amoxapine—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00261	0.00593	CbGeAlD
Amoxapine—DRD3—brain—amyotrophic lateral sclerosis	0.00259	0.00587	CbGeAlD
Amoxapine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00662	CcSEcCtD
Amoxapine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00657	CcSEcCtD
Amoxapine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00656	CcSEcCtD
Amoxapine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00652	CcSEcCtD
Amoxapine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.0025	0.00568	CbGeAlD
Amoxapine—HTR6—brain—amyotrophic lateral sclerosis	0.00249	0.00565	CbGeAlD
Amoxapine—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00248	0.00564	CbGeAlD
Amoxapine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00242	0.0055	CbGeAlD
Amoxapine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00619	CcSEcCtD
Amoxapine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00234	0.00531	CbGeAlD
Amoxapine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00233	0.00529	CbGeAlD
Amoxapine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00233	0.00529	CbGeAlD
Amoxapine—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00233	0.00529	CbGeAlD
Amoxapine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00231	0.00524	CbGeAlD
Amoxapine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00225	0.00511	CbGeAlD
Amoxapine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00223	0.00507	CbGeAlD
Amoxapine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00212	0.0048	CbGeAlD
Amoxapine—ORM1—nervous system—amyotrophic lateral sclerosis	0.00209	0.00475	CbGeAlD
Amoxapine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00209	0.00474	CbGeAlD
Amoxapine—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00202	0.00457	CbGeAlD
Amoxapine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00201	0.00457	CbGeAlD
Amoxapine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00197	0.00446	CbGeAlD
Amoxapine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00196	0.00445	CbGeAlD
Amoxapine—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00196	0.00445	CbGeAlD
Amoxapine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00195	0.00442	CbGeAlD
Amoxapine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00429	CbGeAlD
Amoxapine—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00429	CbGeAlD
Amoxapine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00188	0.00427	CbGeAlD
Amoxapine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00188	0.00427	CbGeAlD
Amoxapine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00187	0.00425	CbGeAlD
Amoxapine—DRD1—brain—amyotrophic lateral sclerosis	0.00185	0.0042	CbGeAlD
Amoxapine—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00185	0.00419	CbGeAlD
Amoxapine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00183	0.00416	CbGeAlD
Amoxapine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00181	0.00411	CbGeAlD
Amoxapine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.0018	0.00409	CbGeAlD
Amoxapine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.0018	0.00408	CbGeAlD
Amoxapine—HTR3A—brain—amyotrophic lateral sclerosis	0.00179	0.00406	CbGeAlD
Amoxapine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00178	0.00405	CbGeAlD
Amoxapine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00178	0.00403	CbGeAlD
Amoxapine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00177	0.00401	CbGeAlD
Amoxapine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00172	0.0039	CbGeAlD
Amoxapine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00171	0.00388	CbGeAlD
Amoxapine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.0017	0.00386	CbGeAlD
Amoxapine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00164	0.00373	CbGeAlD
Amoxapine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00158	0.00359	CbGeAlD
Amoxapine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00157	0.00356	CbGeAlD
Amoxapine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00152	0.00346	CbGeAlD
Amoxapine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00151	0.00344	CbGeAlD
Amoxapine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00151	0.00343	CbGeAlD
Amoxapine—HTR1B—brain—amyotrophic lateral sclerosis	0.0015	0.0034	CbGeAlD
Amoxapine—GABRA1—brain—amyotrophic lateral sclerosis	0.0015	0.0034	CbGeAlD
Amoxapine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00149	0.00338	CbGeAlD
Amoxapine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00149	0.00338	CbGeAlD
Amoxapine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00148	0.00335	CbGeAlD
Amoxapine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00146	0.00331	CbGeAlD
Amoxapine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00146	0.00331	CbGeAlD
Amoxapine—HTR2C—brain—amyotrophic lateral sclerosis	0.00144	0.00326	CbGeAlD
Amoxapine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00143	0.00325	CbGeAlD
Amoxapine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00142	0.00323	CbGeAlD
Amoxapine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00319	CbGeAlD
Amoxapine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00138	0.00313	CbGeAlD
Amoxapine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00137	0.00312	CbGeAlD
Amoxapine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00136	0.00309	CbGeAlD
Amoxapine—CHRM1—brain—amyotrophic lateral sclerosis	0.00136	0.00308	CbGeAlD
Amoxapine—HTR2B—brain—amyotrophic lateral sclerosis	0.00135	0.00307	CbGeAlD
Amoxapine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00135	0.00306	CbGeAlD
Amoxapine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00132	0.00299	CbGeAlD
Amoxapine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00126	0.00285	CbGeAlD
Amoxapine—HTR1A—brain—amyotrophic lateral sclerosis	0.00121	0.00275	CbGeAlD
Amoxapine—SLC6A2—brain—amyotrophic lateral sclerosis	0.0012	0.00272	CbGeAlD
Amoxapine—HTR7—brain—amyotrophic lateral sclerosis	0.00116	0.00263	CbGeAlD
Amoxapine—HRH1—nervous system—amyotrophic lateral sclerosis	0.00113	0.00257	CbGeAlD
Amoxapine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00112	0.00254	CbGeAlD
Amoxapine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00112	0.00253	CbGeAlD
Amoxapine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00111	0.00252	CbGeAlD
Amoxapine—DRD2—brain—amyotrophic lateral sclerosis	0.00109	0.00248	CbGeAlD
Amoxapine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00109	0.00247	CbGeAlD
Amoxapine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00107	0.00243	CbGeAlD
Amoxapine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00104	0.00237	CbGeAlD
Amoxapine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000944	0.00214	CbGeAlD
Amoxapine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000909	0.00206	CbGeAlD
Amoxapine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000888	0.00202	CbGeAlD
Amoxapine—HRH1—brain—amyotrophic lateral sclerosis	0.000864	0.00196	CbGeAlD
Amoxapine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00086	0.00195	CbGeAlD
Amoxapine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000849	0.00193	CbGeAlD
Amoxapine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000828	0.00188	CbGeAlD
Amoxapine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000809	0.00184	CbGeAlD
Amoxapine—HTR2A—brain—amyotrophic lateral sclerosis	0.000721	0.00164	CbGeAlD
Amoxapine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000657	0.00149	CbGeAlD
Amoxapine—HTR1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.62e-05	0.000407	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.58e-05	0.000404	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.55e-05	0.000402	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.52e-05	0.0004	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.46e-05	0.000397	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	6.42e-05	0.000394	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.38e-05	0.000392	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.34e-05	0.000389	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.33e-05	0.000389	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.31e-05	0.000388	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.3e-05	0.000387	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.22e-05	0.000382	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.16e-05	0.000378	CbGpPWpGaD
Amoxapine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	6.13e-05	0.000377	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.11e-05	0.000376	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.06e-05	0.000373	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.06e-05	0.000372	CbGpPWpGaD
Amoxapine—CHRM1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	6e-05	0.000369	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6e-05	0.000368	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.97e-05	0.000367	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.95e-05	0.000366	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.95e-05	0.000365	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.94e-05	0.000365	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.93e-05	0.000365	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.9e-05	0.000362	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.89e-05	0.000362	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.87e-05	0.000361	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.87e-05	0.00036	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.84e-05	0.000359	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.79e-05	0.000356	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.79e-05	0.000355	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.78e-05	0.000355	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.78e-05	0.000355	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.71e-05	0.000351	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.68e-05	0.000349	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.68e-05	0.000349	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.66e-05	0.000348	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.66e-05	0.000347	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.56e-05	0.000341	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.53e-05	0.00034	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	5.52e-05	0.000339	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.5e-05	0.000338	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.46e-05	0.000335	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.43e-05	0.000333	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.43e-05	0.000333	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.41e-05	0.000333	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.38e-05	0.000331	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.37e-05	0.00033	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	5.32e-05	0.000327	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.21e-05	0.00032	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.17e-05	0.000318	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.12e-05	0.000314	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	5.09e-05	0.000313	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.05e-05	0.00031	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.05e-05	0.00031	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.02e-05	0.000308	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.01e-05	0.000308	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.93e-05	0.000303	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.92e-05	0.000302	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.91e-05	0.000301	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.88e-05	0.0003	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.87e-05	0.000299	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.85e-05	0.000298	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.84e-05	0.000297	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.83e-05	0.000297	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.81e-05	0.000295	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.8e-05	0.000295	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.79e-05	0.000294	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.77e-05	0.000293	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.71e-05	0.000289	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.7e-05	0.000289	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.69e-05	0.000288	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.67e-05	0.000287	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.63e-05	0.000285	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.56e-05	0.00028	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.55e-05	0.00028	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.49e-05	0.000276	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.43e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.43e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.42e-05	0.000272	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.4e-05	0.00027	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.38e-05	0.000269	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.37e-05	0.000268	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.36e-05	0.000268	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.36e-05	0.000268	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.35e-05	0.000267	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.34e-05	0.000266	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.27e-05	0.000262	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.19e-05	0.000257	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	4.18e-05	0.000257	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.17e-05	0.000256	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.17e-05	0.000256	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.16e-05	0.000256	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.12e-05	0.000253	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.12e-05	0.000253	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.05e-05	0.000249	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.04e-05	0.000248	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.03e-05	0.000248	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.03e-05	0.000247	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.02e-05	0.000247	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.01e-05	0.000246	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.97e-05	0.000244	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.97e-05	0.000244	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.92e-05	0.000241	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.91e-05	0.00024	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.87e-05	0.000238	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.86e-05	0.000237	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.85e-05	0.000237	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.8e-05	0.000234	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.79e-05	0.000233	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.79e-05	0.000233	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.78e-05	0.000232	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.75e-05	0.00023	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.74e-05	0.00023	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.72e-05	0.000229	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.69e-05	0.000227	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.68e-05	0.000226	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.68e-05	0.000226	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.64e-05	0.000224	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.62e-05	0.000222	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.61e-05	0.000222	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.6e-05	0.000221	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.59e-05	0.00022	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.58e-05	0.00022	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.57e-05	0.000219	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.55e-05	0.000218	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.47e-05	0.000213	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.47e-05	0.000213	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.46e-05	0.000212	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.45e-05	0.000212	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.42e-05	0.00021	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.42e-05	0.00021	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.4e-05	0.000209	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.37e-05	0.000207	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.36e-05	0.000206	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.29e-05	0.000202	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.23e-05	0.000198	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.18e-05	0.000196	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.17e-05	0.000195	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.15e-05	0.000194	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.1e-05	0.00019	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.1e-05	0.00019	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.09e-05	0.00019	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.09e-05	0.00019	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.08e-05	0.000189	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.03e-05	0.000186	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.01e-05	0.000185	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.98e-05	0.000183	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.97e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.96e-05	0.000182	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.96e-05	0.000182	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.91e-05	0.000179	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.91e-05	0.000179	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.9e-05	0.000178	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.85e-05	0.000175	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.83e-05	0.000174	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.82e-05	0.000173	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.78e-05	0.00017	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.76e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.67e-05	0.000164	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.65e-05	0.000163	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.63e-05	0.000162	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.62e-05	0.000161	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.62e-05	0.000161	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.61e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.58e-05	0.000158	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.57e-05	0.000158	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.57e-05	0.000158	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.56e-05	0.000157	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.52e-05	0.000155	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.44e-05	0.00015	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.4e-05	0.000147	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.39e-05	0.000147	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.38e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.38e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.38e-05	0.000146	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.35e-05	0.000144	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.34e-05	0.000144	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.32e-05	0.000142	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.29e-05	0.000141	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.28e-05	0.00014	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.28e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.25e-05	0.000138	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.25e-05	0.000138	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.25e-05	0.000138	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.19e-05	0.000135	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.18e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.18e-05	0.000134	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.15e-05	0.000132	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.07e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.06e-05	0.000126	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.05e-05	0.000126	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.03e-05	0.000124	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.02e-05	0.000124	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.02e-05	0.000124	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-05	0.000124	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.98e-05	0.000122	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.98e-05	0.000121	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.97e-05	0.000121	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.97e-05	0.000121	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.94e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.94e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.93e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.91e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.85e-05	0.000113	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.8e-05	0.000111	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.79e-05	0.00011	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.77e-05	0.000108	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.76e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.74e-05	0.000107	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.72e-05	0.000106	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.7e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.67e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.66e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-05	9.52e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.53e-05	9.39e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.53e-05	9.38e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.52e-05	9.37e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.52e-05	9.35e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.52e-05	9.32e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.5e-05	9.2e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.49e-05	9.17e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.49e-05	9.15e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.49e-05	9.13e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.46e-05	9e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.46e-05	8.98e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.44e-05	8.85e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.44e-05	8.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.43e-05	8.81e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.41e-05	8.67e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.4e-05	8.57e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.39e-05	8.52e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.32e-05	8.09e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.32e-05	8.08e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.31e-05	8.05e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.3e-05	7.98e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.29e-05	7.95e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.29e-05	7.93e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.29e-05	7.91e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.27e-05	7.78e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.18e-05	7.23e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	7.16e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.13e-05	6.95e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.13e-05	6.92e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.94e-06	6.1e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.78e-06	6.01e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.76e-06	5.99e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.73e-06	5.97e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.57e-06	5.88e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.9e-06	5.46e-05	CbGpPWpGaD
